Zepbound, a newly approved obesity drug from Eli Lilly, hit the market Dec. 5.
Read the full post on Becker's Hospital Review - Healthcare News
Zepbound, a newly approved obesity drug from Eli Lilly, hit the market Dec. 5.
Read the full post on Becker's Hospital Review - Healthcare News